DNA pattern of human pituitary tumors.
The tumor tissue from 62 consecutive patients with pituitary adenomas was analyzed with regard to ploidy and percentage of cells in different phases of the cell cycle by use of flow-cytofluorometry. In six of 62 cases, two tumor-cell populations were identified; therefore the study material comprised 68 cell lines. Approximately half of the cell lines were diploid (33 of 68, or 49 per cent); five of 68 (7 per cent) were hypodiploid, and 30 of 68 (44 per cent) were hyperdiploid-aneuploid. A low occurrence of aneuploid cell lines appeared in hormonally nonsecreting tumors (22 per cent). An aneuploid DNA pattern was predominantly found in prolactinomas (70 per cent). In acromegaly, tumors secreting growth hormone had only an aneuploid DNA pattern in 41 per cent of the cases, whereas 67 per cent of the tumors with concomitant secretion of growth hormone and prolactin were aneuploid. The latter group also comprised the largest number of adenomas with two cell lines and all but one hypodiploid tumor. Most tumors with an aggressive clinical course were either aneuploid or diploid but with a high percentage of proliferating cells.
D000236:Adenoma / Q000032:analysis*; D000328:Adult; D000368:Aged; D002453:Cell Cycle; D002869:Chromosome Aberrations; D004273:DNA, Neoplasm / Q000032:analysis* / Q000235:genetics; D005434:Flow Cytometry; D013006:Growth Hormone / Q000378:metabolism; D006801:Humans; D008875:Middle Aged; D010911:Pituitary Neoplasms / Q000032:analysis* / Q000378:metabolism; D011003:Ploidies; D011388:Prolactin / Q000378:metabolism
D004273:DNA, Neoplasm; D011388:Prolactin; D013006:Growth Hormone